NO891007L - Farmasoeytiske polypeptidholdige preparater. - Google Patents
Farmasoeytiske polypeptidholdige preparater.Info
- Publication number
- NO891007L NO891007L NO89891007A NO891007A NO891007L NO 891007 L NO891007 L NO 891007L NO 89891007 A NO89891007 A NO 89891007A NO 891007 A NO891007 A NO 891007A NO 891007 L NO891007 L NO 891007L
- Authority
- NO
- Norway
- Prior art keywords
- carboxylic acid
- nonionic surfactant
- aliphatic carboxylic
- biologically active
- medium chain
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 1
- 229940124532 absorption promoter Drugs 0.000 abstract 3
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 abstract 3
- 239000002736 nonionic surfactant Substances 0.000 abstract 3
- 239000003945 anionic surfactant Substances 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102000055006 Calcitonin Human genes 0.000 abstract 1
- 108060001064 Calcitonin Proteins 0.000 abstract 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 abstract 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 abstract 1
- 125000000129 anionic group Chemical group 0.000 abstract 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 abstract 1
- 229960004015 calcitonin Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gynecology & Obstetrics (AREA)
- Immunology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16716388A | 1988-03-11 | 1988-03-11 | |
| US31550289A | 1989-03-01 | 1989-03-01 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO891007D0 NO891007D0 (no) | 1989-03-09 |
| NO891007L true NO891007L (no) | 1989-09-12 |
| NO179479B NO179479B (no) | 1996-07-08 |
| NO179479C NO179479C (no) | 1996-10-16 |
Family
ID=26862907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO891007A NO179479C (no) | 1988-03-11 | 1989-03-09 | Fremgangsmåte for fremstilling av et intravaginalt farmasöytisk preparat |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5840685A (no) |
| EP (1) | EP0332222B1 (no) |
| JP (1) | JP2801249B2 (no) |
| KR (1) | KR0138658B1 (no) |
| AT (1) | ATE128874T1 (no) |
| AU (1) | AU617157B2 (no) |
| CA (1) | CA1336676C (no) |
| CZ (1) | CZ278971B6 (no) |
| DE (2) | DE332222T1 (no) |
| DK (1) | DK116789A (no) |
| ES (1) | ES2078222T3 (no) |
| GR (1) | GR900300006T1 (no) |
| NO (1) | NO179479C (no) |
| NZ (1) | NZ228285A (no) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5981485A (en) * | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| JP2911496B2 (ja) * | 1989-09-11 | 1999-06-23 | 帝國製薬株式会社 | 生理活性ポリペプチド含有高吸収性経膣剤 |
| JPH078804B2 (ja) * | 1990-08-28 | 1995-02-01 | 三菱化学株式会社 | 副腎皮質刺激ホルモン放出因子含有製剤 |
| JP3628713B2 (ja) * | 1993-06-07 | 2005-03-16 | 帝國製薬株式会社 | 生理学的に活性なペプチドを含有する膣投与製剤 |
| WO1996020726A1 (en) * | 1994-12-29 | 1996-07-11 | Mochida Pharmaceutical Co., Ltd. | Urinastatin-containing suppository |
| GB2318056B (en) * | 1995-08-08 | 1999-05-26 | Danbiosyst Uk | Composition for enhanced uptake of polar drugs from the colon |
| GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
| US7153845B2 (en) * | 1998-08-25 | 2006-12-26 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
| US8765177B2 (en) | 1997-09-12 | 2014-07-01 | Columbia Laboratories, Inc. | Bioadhesive progressive hydration tablets |
| US6043259A (en) * | 1998-07-09 | 2000-03-28 | Medicure Inc. | Treatment of cardiovascular and related pathologies |
| US20070148228A1 (en) * | 1999-02-22 | 2007-06-28 | Merrion Research I Limited | Solid oral dosage form containing an enhancer |
| US8119159B2 (en) * | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
| US7658938B2 (en) * | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
| BR0008857A (pt) | 1999-03-08 | 2001-12-18 | Medicure Inc | Análogos de piridoxal para distúrbios da vitaminab-6 |
| EP1187639A1 (en) | 1999-06-04 | 2002-03-20 | Delrx Pharmaceutical Corporation | Formulations comprising dehydrated particles of pharmaceutical agents and process for preparing the same |
| EP1196171A2 (en) * | 1999-07-13 | 2002-04-17 | Medicure Inc. | Use of pyridoxin derivatives for the treatment of diabetes and related complications |
| US6677356B1 (en) * | 1999-08-24 | 2004-01-13 | Medicure International Inc. | Treatment of cardiovascular and related pathologies |
| US7442689B2 (en) * | 2000-02-29 | 2008-10-28 | Medicure International Inc. | Cardioprotective phosphonates and malonates |
| PT1268498E (pt) | 2000-02-29 | 2005-07-29 | Medicure Int Inc | Fosfonatos cardioprotectores |
| AU784840B2 (en) | 2000-03-28 | 2006-07-06 | Medicure International Inc. | Treatment of cerebrovascular disease |
| DE60130007T2 (de) * | 2000-06-27 | 2008-04-30 | Qualilife Pharmaceuticals Inc. | Zusammensetzungen und verfahren zur behandlung der weiblichen sexuellen reaktion |
| ATE364595T1 (de) | 2000-07-07 | 2007-07-15 | Medicure Int Inc | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika |
| US6897228B2 (en) | 2000-07-07 | 2005-05-24 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: new uses |
| US6548519B1 (en) | 2001-07-06 | 2003-04-15 | Medicure International Inc. | Pyridoxine and pyridoxal analogues: novel uses |
| DE60116520T2 (de) * | 2000-10-10 | 2006-08-31 | Microchips, Inc., Bedford | Microchip-reservoir-vorrichtungen mit drahtloser übertragung von energie und daten |
| US6875208B2 (en) * | 2001-05-31 | 2005-04-05 | Massachusetts Institute Of Technology | Microchip devices with improved reservoir opening |
| JP2005505429A (ja) | 2001-06-28 | 2005-02-24 | マイクロチップス・インコーポレーテッド | マイクロチップリザーバデバイスを密閉シーリングするための方法 |
| WO2004022033A1 (en) * | 2002-09-04 | 2004-03-18 | Microchips, Inc. | Method and device for the controlled delivery of parathyroid hormone |
| US20060122095A1 (en) * | 2002-09-12 | 2006-06-08 | Brid Delvin | Mucus formulation for mucosal surfaces and uses thereof |
| US20040186077A1 (en) * | 2003-03-17 | 2004-09-23 | Medicure International Inc. | Novel heteroaryl phosphonates as cardioprotective agents |
| ATE461681T1 (de) * | 2003-04-29 | 2010-04-15 | Gen Hospital Corp | Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln |
| US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
| KR20070044805A (ko) * | 2004-04-15 | 2007-04-30 | 키아스마, 인코포레이티드 | 생물학적 장벽 투과를 촉진시킬 수 있는 조성물 |
| US20070060549A1 (en) * | 2004-08-10 | 2007-03-15 | Friesen Albert D | Combination therapies employing ace inhibitors and uses thereof for the treatment of diabetic disorders |
| US7812037B2 (en) | 2004-10-28 | 2010-10-12 | Medicure International, Inc. | Dual antiplatelet/anticoagulant pyridoxine analogs |
| US7459468B2 (en) | 2004-10-28 | 2008-12-02 | Medicure International, Inc. | Aryl sulfonic pyridoxines as antiplatelet agents |
| US20080076975A1 (en) * | 2005-01-25 | 2008-03-27 | Microchips, Inc. | Method and implantable device with reservoir array for pre-clinical in vivo testing |
| EP1843783B1 (en) * | 2005-01-25 | 2012-05-30 | MicroCHIPS, Inc. | Control of drug release by transient modification of local microenvironments |
| AU2007235251B2 (en) | 2006-04-07 | 2013-02-07 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
| CA2654566A1 (en) * | 2006-06-09 | 2007-12-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
| BRPI0912384A2 (pt) * | 2008-05-07 | 2015-10-13 | Merrion Res Iii Ltd | composição, e, método para preparar uma composição |
| KR101814186B1 (ko) | 2008-09-17 | 2018-03-14 | 키아스마 인코포레이티드 | 약제학적 조성물 및 연관된 투여방법 |
| JP5409067B2 (ja) * | 2009-03-23 | 2014-02-05 | ユニ・チャーム株式会社 | タンポン |
| US9089484B2 (en) | 2010-03-26 | 2015-07-28 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor Xa inhibitors for oral administration |
| KR20140026354A (ko) | 2011-01-07 | 2014-03-05 | 메리온 리서치 Ⅲ 리미티드 | 경구 투여용 철의 제약 조성물 |
| EP3250191B1 (en) | 2015-01-29 | 2024-01-17 | Novo Nordisk A/S | Tablets comprising glp-1 agonist and enteric coating |
| ES3029566T3 (en) | 2015-02-03 | 2025-06-24 | Amryt Endo Inc | Treating acromegaly with oral octreotide |
| US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3888838A (en) * | 1972-07-10 | 1975-06-10 | Ayerst Mckenna & Harrison | Decapeptide having luteinizing hormone (lh)-and follicle stimulating hormone (fsh)-releasing activity, salts and compositions thereof, a process for preparing same, and intermediates therefor |
| JPS563846B2 (no) * | 1972-10-12 | 1981-01-27 | ||
| US4083967A (en) * | 1973-11-01 | 1978-04-11 | Burroughs Wellcome Co. | Nona- and decapeptides |
| US4018726A (en) * | 1975-06-12 | 1977-04-19 | Andrew Victor Schally | [D-Phe6 ]-LH-RH and intermediates therefor |
| US4010125A (en) * | 1975-06-12 | 1977-03-01 | Schally Andrew Victor | [D-Trp6 ]-LH-RH and intermediates therefor |
| IL54041A (en) * | 1978-02-13 | 1981-05-20 | Yissum Res Dev Co | Pharmaceutical compositions for enteral or vaginal application comprising the active ingredient and a nonionic surfactant |
| JPS55153712A (en) * | 1979-05-18 | 1980-11-29 | Kao Corp | Insulin pharmaceutical preparation and its production |
| US4234571A (en) * | 1979-06-11 | 1980-11-18 | Syntex (U.S.A.) Inc. | Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone |
| JPS56122309A (en) * | 1980-03-03 | 1981-09-25 | Teijin Ltd | Calcitonin pharmaceutical for rectal administration |
| JPS5885813A (ja) * | 1981-11-17 | 1983-05-23 | Toyo Jozo Co Ltd | 吸収性良好な製剤 |
| NL193099C (nl) * | 1981-10-30 | 1998-11-03 | Novo Industri As | Gestabiliseerde insuline-oplossing. |
| JPS5921613A (ja) * | 1982-07-28 | 1984-02-03 | Takeda Chem Ind Ltd | 直腸投与製剤 |
| US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
| GB2127689B (en) * | 1982-10-05 | 1986-07-09 | Sandoz Ltd | Calcitonin inhalation compositions |
| DE3576120D1 (de) * | 1984-06-09 | 1990-04-05 | Hoechst Ag | Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung. |
| JPS61267528A (ja) * | 1984-11-26 | 1986-11-27 | Yamanouchi Pharmaceut Co Ltd | 吸収促進剤を含有するカルシトニン経鼻剤 |
| JPS61194034A (ja) * | 1985-02-25 | 1986-08-28 | Teijin Ltd | 経鼻投与用粉末状組成物 |
| JPS6236498A (ja) * | 1985-08-09 | 1987-02-17 | ル・エ−ル・リクイツド・ソシエテ・アノニム・プ−ル・ル・エチユド・エ・ル・エクスプルワテシヨン・デ・プロセデ・ジエオルジエ・クロ−ド | セルロ−ス保護剤 |
| DE3603444A1 (de) * | 1986-02-05 | 1987-08-06 | Thomae Gmbh Dr K | Pharmazeutische zubereitungsformen zur stabilisierung von interferon alpha |
| GR871067B (en) * | 1986-07-18 | 1987-11-19 | Chugai Pharmaceutical Co Ltd | Process for producing stable pharmaceutical preparation containing granulocyte colony stimulating factor |
-
1989
- 1989-03-09 NO NO891007A patent/NO179479C/no unknown
- 1989-03-09 NZ NZ228285A patent/NZ228285A/xx unknown
- 1989-03-10 CA CA000593354A patent/CA1336676C/en not_active Expired - Fee Related
- 1989-03-10 CZ CS891490A patent/CZ278971B6/cs unknown
- 1989-03-10 DK DK116789A patent/DK116789A/da not_active Application Discontinuation
- 1989-03-10 JP JP1058187A patent/JP2801249B2/ja not_active Expired - Fee Related
- 1989-03-11 KR KR1019890002992A patent/KR0138658B1/ko not_active Expired - Fee Related
- 1989-03-13 EP EP89104440A patent/EP0332222B1/en not_active Expired - Lifetime
- 1989-03-13 DE DE198989104440T patent/DE332222T1/de active Pending
- 1989-03-13 ES ES89104440T patent/ES2078222T3/es not_active Expired - Lifetime
- 1989-03-13 AU AU31253/89A patent/AU617157B2/en not_active Ceased
- 1989-03-13 DE DE68924491T patent/DE68924491T2/de not_active Expired - Fee Related
- 1989-03-13 AT AT89104440T patent/ATE128874T1/de active
-
1991
- 1991-06-07 GR GR90300006T patent/GR900300006T1/el unknown
-
1992
- 1992-06-15 US US07/899,165 patent/US5840685A/en not_active Expired - Fee Related
-
1997
- 1997-11-17 US US08/971,329 patent/US5824646A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA1336676C (en) | 1995-08-15 |
| DE332222T1 (de) | 1990-03-22 |
| GR900300006T1 (en) | 1991-06-07 |
| DK116789D0 (da) | 1989-03-10 |
| DE68924491D1 (de) | 1995-11-16 |
| NZ228285A (en) | 1991-08-27 |
| AU617157B2 (en) | 1991-11-21 |
| CZ149089A3 (en) | 1994-03-16 |
| ATE128874T1 (de) | 1995-10-15 |
| NO891007D0 (no) | 1989-03-09 |
| JP2801249B2 (ja) | 1998-09-21 |
| NO179479C (no) | 1996-10-16 |
| AU3125389A (en) | 1989-09-14 |
| CZ278971B6 (en) | 1994-11-16 |
| US5824646A (en) | 1998-10-20 |
| EP0332222A3 (en) | 1991-03-06 |
| DK116789A (da) | 1989-11-28 |
| JPH01294632A (ja) | 1989-11-28 |
| ES2078222T3 (es) | 1995-12-16 |
| NO179479B (no) | 1996-07-08 |
| KR890014131A (ko) | 1989-10-21 |
| EP0332222B1 (en) | 1995-10-11 |
| US5840685A (en) | 1998-11-24 |
| EP0332222A2 (en) | 1989-09-13 |
| KR0138658B1 (ko) | 1998-05-15 |
| DE68924491T2 (de) | 1996-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO891007D0 (no) | Farmasoeytiske polypeptidholdige preparater. | |
| NO883926D0 (no) | Fremgangsmaate for fremstilling av stabilisert humanproteinpreparat. | |
| NO874445L (no) | Farmasoeytiske preparater av rekombinant baa-interferon samt fremstilling og formulering derav. | |
| MD1699F2 (ro) | Compoziţie apoasă a hormonului somatotrop uman şi procedeu de prevenire a denaturării ei | |
| ATE203411T1 (de) | Lagerstabile wässrige pharmazeutische zubereitungen von g-csf | |
| DE69422169D1 (de) | Modifizierte proteine und peptide enthaltende pharmazeutische mittel | |
| MX9302509A (es) | Composiciones de polipeptidos estables en almacenamiento y metodo para su preparacion. | |
| FR2684878B1 (fr) | Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation. | |
| KR950701347A (ko) | 신규한 향종양성 사이토킨(A novel anti-neoplastic cytokine) | |
| DE69112028D1 (de) | Arzneizusammensetzungen zur rektalen Verabreichung enthaltend gefriergetrocknetes Calcitonin. | |
| DK0741579T3 (da) | Vandig formulering med forhalet frigivelse |